Use to detect and differentiate Candida albicans, C. glabrata, C. parapsilosis complex (C. parapsilosis, C. orthopsilosis, C. metapsilosis), C. tropicalis, C. krusei, and C. dubliniensis directly in a clinical specimen. For C. auris screening, refer to Candida auris by PCR (3006370).
Qualitative Polymerase Chain Reaction (PCR)
New York DOH Approval Status
Body fluid, lavender (K2EDTA) or pink (K2EDTA).
Body Fluid: Transfer 1 mL body fluid to a sterile container. (Min: 0.5 mL).
Whole Blood: Transfer 2 mL whole blood to a sterile container. (Min: 1 mL).
Plasma or serum, tissues.
Specimen source required.
Body Fluid: Ambient: Unacceptable; Refrigerated: 2 weeks; Frozen: 2 weeks
Whole Blood: Ambient: Unacceptable; Refrigerated; 1 week; Frozen: 1 week
A negative result does not rule out the presence of PCR inhibitors in the patient specimen or test-specific nucleic acid in concentrations below the level of detection by the test.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration. This test was performed in a CLIA-certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
This test detects and differentiates C. albicans, C. glabrata, C. parapsilosis complex (C. parapsilosis, C. orthopsilosis, C. metapsilosis), C. tropicalis, C. krusei, and C. dubliniensis.
|Component Test Code*||Component Chart Name||LOINC|
|2013785||Candida Species Source||31208-2|
|2013786||Candida albicans by PCR||76580-0|
|2013788||Candida glabrata by PCR|
|2013790||Candida parapsilosis complex by PCR|
|2013792||Candida tropicalis by PCR|
|2013794||Candida krusei by PCR|
|2013796||Candida dubliniensis by PCR|